1. Home
  2. BLFS vs AMPH Comparison

BLFS vs AMPH Comparison

Compare BLFS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

N/A

Current Price

$22.46

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$27.92

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLFS
AMPH
Founded
1987
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
BLFS
AMPH
Price
$22.46
$27.92
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$32.00
$31.00
AVG Volume (30 Days)
344.0K
307.3K
Earning Date
04-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
71.05
17.69
EPS
N/A
1.52
Revenue
$82,254,000.00
$731,967,000.00
Revenue This Year
$18.45
$1.31
Revenue Next Year
$16.27
$4.85
P/E Ratio
N/A
$18.40
Revenue Growth
N/A
13.59
52 Week Low
$19.15
$20.39
52 Week High
$29.57
$31.26

Technical Indicators

Market Signals
Indicator
BLFS
AMPH
Relative Strength Index (RSI) 43.49 46.50
Support Level $20.34 $26.90
Resistance Level $23.00 $27.56
Average True Range (ATR) 0.86 0.90
MACD 0.10 -0.14
Stochastic Oscillator 47.23 15.43

Price Performance

Historical Comparison
BLFS
AMPH

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: